Novel benzoxazole inhibitors of mPGES-1

被引：25

作者：

Kablaoui, Natasha ^{[1
]}

Patel, Snahel ^{[2
]}

Shao, Jay ^{[1
]}

Demian, Douglas ^{[3
]}

Hoffmaster, Keith ^{[4
]}

Berlioz, Francioise ^{[5
]}

Vazquez, Michael L. ^{[6
]}

Moore, William M. ^{[7
]}

Nugent, Richard A. ^{[1
]}

机构：

[1] Pfizer Res Technol Ctr, Cambridge, MA 02139 USA

[2] Genentech Inc, San Francisco, CA 94080 USA

[3] Blue Sky Biotech Inc, Worcester, MA 01605 USA

[4] Novartis Inc, Cambridge, MA 02139 USA

[5] Vertex, Cambridge, MA 02139 USA

[6] Pfizer Global Res, Groton, CT 06340 USA

[7] Monsanto Co, St Louis, MO 63167 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2013年 / 23卷 / 03期

关键词：

mPGES-1; Benzoxazole; Selective; PROSTAGLANDIN-E SYNTHASE-1; EXPRESSION; ARTHRITIS; CARTILAGE; PYRESIS;

D O I：

10.1016/j.bmcl.2012.10.040

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel series of potent benzoxazole mPGES-1 inhibitors has been derived from a hit from a high throughput screen. Compound 37 displays mPGES-1 inhibition in an enzyme assay (0.018 mu M) and PGE-2 inhibition in a cell-based assay (0.034 mu M). It demonstrates 500- and 2500-fold selectivity for mPGES-1 over COX-2 and 6-keto PGF-1 alpha, respectively. In vivo PK studies in dogs demonstrate 55% oral bioavailability and an 7 h half-life. (c) 2012 Elsevier Ltd. All rights reserved.

引用

页码：907 / 911

页数：5

共 16 条

[1] Trisubstituted ureas as potent and selective mPGES-1 inhibitors
Chiasson, Jean-Francois
Boulet, Louise
Brideau, Christine
Chau, Anh
Claveau, David
Cote, Bernard
Ethier, Diane
Giroux, Andre
Guay, Jocelyne
Guiral, Sebastien
Mancini, Joseph
Masse, Frederic
Methot, Nathalie
Riendeau, Denis
Roy, Patrick
Rubin, Joel
Xu, Daigen
Yu, Hongping
Ducharme, Yves
Friesen, Richard W.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (05) : 1488 - 1492
[2] Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors
Cote, Bernard
Boulet, Louise
Brideau, Christine
Claveau, David
Ethier, Diane
Frenette, Richard
Gagnon, Marc
Giroux, Andre
Guay, Jocelyne
Guiral, Sebastien
Mancini, Joseph
Martins, Evelyn
Masse, Frederic
Methot, Nathalie
Riendeau, Denis
Rubin, Joel
Xu, Daigen
Yu, Hongping
Ducharme, Yves
Friesen, Richard W.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (24) : 6816 - 6820
[3] Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: A potential therapeutic target of cartilage degradation
Futani, H
Okayama, A
Matsui, K
Kashiwamura, S
Sasaki, T
Hada, T
Nakanishi, K
Tateishi, H
Maruo, S
Okamura, H
[J]. JOURNAL OF IMMUNOTHERAPY, 2002, 25 : S61 - S64
[4] (1S,2R/1R,2S)-cis-cyclopentyl PNAs (cpPNAs) as constrained PNA analogues:: Synthesis and evaluation of aeg-cpPNA chimera and stereopreferences in hybridization with DNA/RNA
Govindaraju, T
Kumar, VA
Ganesh, KN
[J]. JOURNAL OF ORGANIC CHEMISTRY, 2004, 69 (17) : 5725 - 5734
[5] Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes
Kansy, M
Senner, F
Gubernator, K
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (07) : 1007 - 1010
[6] Prostaglandin E pathophysiology synthase in the of arthritis
Kojima, F
Kato, S
Kawai, S
[J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2005, 19 (03) : 255 - 261
[7] Li XF, 2005, J RHEUMATOL, V32, P887
[8] Cloning, expression, and up-regulation of inducible rat prostaglandin E synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis
Mancini, JA
Blood, K
Guay, J
Gordon, R
Claveau, D
Chan, CC
Riendeau, D
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (06) : 4469 - 4475
[9] Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor
Mbalaviele, Gabriel
Pauley, Adele M.
Shaffer, Alexander F.
Zweifel, Ben S.
Mathialagan, Sumathy
Mnich, Stephen J.
Nemirovskiy, Olga V.
Carter, Jeff
Gierse, James K.
Wang, Jane L.
Vazquez, Michael L.
Moore, William M.
Masferrer, Jaime L.
[J]. BIOCHEMICAL PHARMACOLOGY, 2010, 79 (10) : 1445 - 1454
[10] Future of COX2 inhibitors
Melnikova, I
[J]. NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (06) : 453 - 454

← 1 2 →